156 related articles for article (PubMed ID: 36471083)
21. Orbital Decompression for Compressive Optic Neuropathy in Patients with a Metastatic Orbital Tumor from Breast Carcinoma.
Takahashi Y; Kakizaki H
Orbit; 2015 Jun; 34(3):137-41. PubMed ID: 25849137
[TBL] [Abstract][Full Text] [Related]
22. Vision-related quality of life after transsphenoidal surgery for pituitary adenoma.
Okamoto Y; Okamoto F; Yamada S; Honda M; Hiraoka T; Oshika T
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3405-10. PubMed ID: 20181847
[TBL] [Abstract][Full Text] [Related]
23. Improved Vision from Severe Compressive Optic Neuropathy by Apical Cavernous Hemangioma.
Kang H; Takahashi Y; Nishimura K; Yasuda M; Akutsu H; Kakizaki H
Case Rep Ophthalmol; 2016; 7(1):179-83. PubMed ID: 27099610
[TBL] [Abstract][Full Text] [Related]
24. Critical flicker fusion test of potential vision.
Shankar H; Pesudovs K
J Cataract Refract Surg; 2007 Feb; 33(2):232-9. PubMed ID: 17276263
[TBL] [Abstract][Full Text] [Related]
25. [The nonfunctional pituitary adenoma, The optic chiasm syndrome].
Stefaniu I; Niţă N; Zemba M; Niţulescu C; Chirilă D; Zamfir C
Oftalmologia; 2000; 50(1):79-83. PubMed ID: 11021111
[TBL] [Abstract][Full Text] [Related]
26. The clinical application of critical flicker fusion frequency in demyelinating optic neuritis.
Fu J; Wang Y; Tan S; Xu G; Zhou H; Xu Q; Wei S
Adv Ophthalmol Pract Res; 2021 Dec; 1(2):100011. PubMed ID: 37846319
[TBL] [Abstract][Full Text] [Related]
27. Vision-related quality of life in patients with pituitary adenoma.
Okamoto Y; Okamoto F; Hiraoka T; Yamada S; Oshika T
Am J Ophthalmol; 2008 Aug; 146(2):318-322. PubMed ID: 18538298
[TBL] [Abstract][Full Text] [Related]
28. Her vision was tied down.
Dorotheo EU; Tang RA; Bahrani HM; Schiffman JS; Bhatti MT; Lewis SB
Surv Ophthalmol; 2005; 50(6):588-97. PubMed ID: 16263371
[TBL] [Abstract][Full Text] [Related]
29. [Value of mfVEP test in pituitary tumors diagnosis].
Piekarska A; Lubiński W; Gosławski W; Wieliczko W; Syrenicz A; Olszowski T; Karczewicz D
Klin Oczna; 2008; 110(7-9):247-51. PubMed ID: 19112855
[TBL] [Abstract][Full Text] [Related]
30. Optic nerve hyperintensity on T2-weighted images among patients with pituitary macroadenoma: correlation with visual impairment.
Tokumaru AM; Sakata I; Terada H; Kosuda S; Nawashiro H; Yoshii M
AJNR Am J Neuroradiol; 2006 Feb; 27(2):250-4. PubMed ID: 16484385
[TBL] [Abstract][Full Text] [Related]
31. [Macular pathology as a cause of visual impairment?].
Matlach J; Nowak J; Pérez Tejón JM; Göbel W
Ophthalmologe; 2013 Aug; 110(8):761-5. PubMed ID: 23765371
[TBL] [Abstract][Full Text] [Related]
32. [Assessment of compressive optic neuropathy in hipofizar tumors].
Predoi DV; Badiu C; Dărăban C; Stângu C; Dumitrache M
Oftalmologia; 2008; 52(4):110-7. PubMed ID: 19354173
[TBL] [Abstract][Full Text] [Related]
33. The Utility of Magnetic Resonance Imaging in Assessing Patients With Pituitary Tumors Compressing the Anterior Visual Pathway.
Ryu WHA; Starreveld Y; Burton JM; Liu J; Costello F;
J Neuroophthalmol; 2017 Sep; 37(3):230-238. PubMed ID: 27391942
[TBL] [Abstract][Full Text] [Related]
34. Predictors for visual dysfunction in nonfunctioning pituitary adenomas - implications for neurosurgical management.
Schmalisch K; Milian M; Schimitzek T; Lagrèze WA; Honegger J
Clin Endocrinol (Oxf); 2012 Nov; 77(5):728-34. PubMed ID: 22747829
[TBL] [Abstract][Full Text] [Related]
35. Severe optic neuropathy caused by dichloromethane inhalation.
Kobayashi A; Ando A; Tagami N; Kitagawa M; Kawai E; Akioka M; Arai E; Nakatani T; Nakano S; Matsui Y; Matsumura M
J Ocul Pharmacol Ther; 2008 Dec; 24(6):607-12. PubMed ID: 19049266
[TBL] [Abstract][Full Text] [Related]
36. Optical coherence tomography detects early optic nerve damage before visual field defect in patients with pituitary tumors.
Sasagawa Y; Nakahara M; Takemoto D; Nakada M
Neurosurg Rev; 2023 Apr; 46(1):85. PubMed ID: 37058150
[TBL] [Abstract][Full Text] [Related]
37. Clinical features associated with lesions other than pituitary adenoma in patients with an optic chiasmal syndrome: a new perspective.
Derakhshan I
Am J Ophthalmol; 2005 Feb; 139(2):394-5; author reply 395. PubMed ID: 15734029
[No Abstract] [Full Text] [Related]
38. Critical flicker-fusion frequency in age-related macular degeneration.
Maier M; Groneberg T; Specht H; Lohmann CP
Graefes Arch Clin Exp Ophthalmol; 2010 Mar; 248(3):409-13. PubMed ID: 20076964
[TBL] [Abstract][Full Text] [Related]
39. [Basic and clinical aspects of modern perimetry].
Otori T
Nippon Ganka Gakkai Zasshi; 1998 Dec; 102(12):779-95. PubMed ID: 10025112
[TBL] [Abstract][Full Text] [Related]
40. Is critical flicker-fusion frequency a valid measure of visual fatigue? A post-hoc analysis of a double-masked randomised controlled trial.
Singh S; Downie LE; Anderson AJ
Ophthalmic Physiol Opt; 2023 Mar; 43(2):176-182. PubMed ID: 36416367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
